Published online before print July 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Departments of Medicine, School of Medicine, and
Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia
1Correspondence: University of Pennsylvania School of Medicine, 522 Johnson Pavilion, 36th & Hamilton Walk, Philadelphia, PA 19104. E-mail: collmanr{at}mail.med.upenn.edu
Macrophages are major targets for infection by human immunodeficiency virus type 1 (HIV-1). In addition to their role as productive viral reservoirs, inappropriate activation of infected and uninfected macrophages appears to contribute to pathogenesis. HIV-1 infection requires initial interactions between the viral envelope surface glycoprotein gp120, the cell-surface protein CD4, and a chemokine receptor CCR5 or CXCR4. Besides their role in HIV-1 entry, CCR5 and CXCR4 are G protein-coupled receptors that can activate multiple intracellular signaling pathways. HIV-1 gp120 has been shown to activate signaling pathways through the chemokine receptors in several cell types including lymphocytes, neurons, and astrocytes. In some cell types, these consequences may cause cellular injury. In this review, we highlight our data demonstrating diverse signaling events that occur in primary human macrophages in response to gp120/chemokine receptor interactions. These responses include K+, Cl, and nonselective cation currents, intracellular Ca2+ increases, and activation of several kinases including the focal adhesion-related tyrosine kinase Pyk2, mitogen-activated protein kinases (MAPK), and phosphoinositol-3 kinase. Activation of the MAPK leads to gp120-induced expression of chemokines such as monocyte chemoattractant protein-1 and macrophage-inflammatory protein-1ß and the proinflammatory cytokine tumor necrosis factor
. These responses establish a complex cytokine network, which may enhance or suppress HIV-1 replication. In addition, dysregulation of macrophage function by gp120/chemokine receptor signaling may contribute to local inflammation and injury and further recruit additional inflammatory and/or target cells. Targeting these cellular signaling pathways may have benefit in controlling inflammatory sequelae of HIV infection such as in neurological disease.
Key Words: signal transduction chemokine receptor AIDS dementia HIV encephalopathy
This article has been cited by other articles:
![]() |
B. Harmon and L. Ratner Induction of the G{alpha}q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry J. Virol., September 15, 2008; 82(18): 9191 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bachis, S. A. Aden, R. L. Nosheny, P. M. Andrews, and I. Mocchetti Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. J. Neurosci., June 21, 2006; 26(25): 6771 - 6780. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nimura, L. F. Zhang, K. Okuma, R. Tanaka, H. Sunakawa, N. Yamamoto, and Y. Tanaka Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells. Experimental Biology and Medicine, April 1, 2006; 231(4): 431 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cicala, J. Arthos, E. Martinelli, N. Censoplano, C. C. Cruz, E. Chung, S. M. Selig, D. Van Ryk, J. Yang, S. Jagannatha, et al. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells PNAS, March 7, 2006; 103(10): 3746 - 3751. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ghaffari, D. L. Tuttle, D. Briggs, B. R. Burkhardt, D. Bhatt, W. A. Andiman, J. W. Sleasman, and M. M. Goodenow Complex Determinants in Human Immunodeficiency Virus Type 1 Envelope gp120 Mediate CXCR4-Dependent Infection of Macrophages J. Virol., November 1, 2005; 79(21): 13250 - 13261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S L-F Pender, V Chance, C V Whiting, M Buckley, M Edwards, R Pettipher, and T T MacDonald Systemic administration of the chemokine macrophage inflammatory protein 1{alpha} exacerbates inflammatory bowel disease in a mouse model Gut, August 1, 2005; 54(8): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balabanian, J. Harriague, C. Decrion, B. Lagane, S. Shorte, F. Baleux, J.-L. Virelizier, F. Arenzana-Seisdedos, and L. A. Chakrabarti CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes J. Immunol., December 15, 2004; 173(12): 7150 - 7160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Collman, C.-F. Perno, S. M. Crowe, M. Stevenson, and L. J. Montaner HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions J. Leukoc. Biol., November 1, 2003; 74(5): 631 - 634. [Abstract] [Full Text] [PDF] |
||||